A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol

BACKGROUND: Vascular dementia is the second most common cause of dementia affecting over seven million people worldwide, yet there are no licensed treatments. There is an urgent need for a clinical trial in this patient group. Subcortical ischaemic vascular dementia is the most common variant of vas...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenan, Caroline, Murphy, Lynn, Yu, Ly-Mee, Kehoe, Patrick G., Coulthard, Elizabeth, Bath, Philip, Stewart, Robert, Jones, Rob, Corbett, Anne, Thomas, Alan, Connelly, Peter, Arrojo, Frank, Canning, Rachel, Wallach, Sylvia, Henderson, Catherine, McGuinness, Bernadette, O’Sullivan, Mike, Holmes, Clive, Knapp, Martin, Ballard, Clive, Passmore, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950108/
https://www.ncbi.nlm.nih.gov/pubmed/27430267
http://dx.doi.org/10.1186/s13063-016-1449-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950108/
https://www.ncbi.nlm.nih.gov/pubmed/27430267
http://dx.doi.org/10.1186/s13063-016-1449-3

Ejemplares similares